Skip To Main Content
Lilly
Menu closed
Lilly
  • Medical Home
  • Medical Education
      • All Therapeutic Areas
        • Alopecia Areata
        • Atopic Dermatitis
        • Psoriasis
        • Diabetes
        • Hypoglycemia
        • Inflammatory Bowel Disease
        • Ulcerative Colitis
        • COVID-19
        • Headache Disorders
        • Neurodegeneration
        • Breast Cancer
        • Hematologic Cancer
        • Axial Spondyloarthritis
        • Psoriatic Arthritis
        • Rheumatoid Arthritis
        • Resources
      • All Therapeutic Areas
        • Alopecia Areata
        • Atopic Dermatitis
        • Psoriasis
        • Diabetes
        • Hypoglycemia
        • Inflammatory Bowel Disease
        • Depression
        • Headache Disorders
        • Breast Cancer
        • Gastrointestinal Cancer
        • Oncology General
        • Osteoporosis
        • Rheumatoid Arthritis
        • Resources
  • Independent Medical Education
      • Alopecia Areata
      • Atopic Dermatitis
      • Psoriasis
    • Diabetes
      • Ulcerative Colitis
      • COVID-19
      • Headache Disorders
      • Neurodegeneration
    • Obesity
      • Breast Cancer
      • Gastrointestinal Cancer
      • Hematologic Cancer
      • Non-small Cell Lung Cancer
      • Prostate Cancer
      • Oncology General
      • Precision Medicine and Diagnostics
      • Axial Spondyloarthritis
      • Systemic Lupus Erythematosus
      • Psoriatic Arthritis
      • Rheumatoid Arthritis
  • Chat Contact Us

Disease Education Resources

Oncology

Please select your disease state of interest to explore medical education resources.

Hematologic Cancer

Mantle Cell Lymphoma

Mantle Cell Lymphoma

Here you will find medical slide sets about Mantle Cell Lymphoma (MCL), including a disease overview and risk factors for poor prognosis.

Program
Understanding Reversible Bruton Tyrosine Kinase (BTK) Inhibition in B Cell Malignancies

Understanding Reversible Bruton Tyrosine Kinase (BTK) Inhibition in B Cell Malignancies

Explore our educational materials about BTK inhibition in the treatment of B-cell malignancies, and a growing unmet need of resistance to covalent BTK inhibition.

Program
Understanding Bruton Tyrosine Kinase (BTK) Pathway Inhibition in B-cell Malignancies​

This slide deck provides information on covalent and reversible (non-covalent) BTK inhibition in the treatment of B-cell malignancies, and a growing unmet need of resistance to covalent BTK inhibition.




Patient Education Resources

Explore our library of patient based education materials to aid in HCP to patient interactions.

Review patient resources
  • Copyright
  • Terms of Use
  • Privacy Statement
  • Accessibility Statement
  • Sitemap

To speak to customer support:
Call (XXX) XXX-XXXX

This site is intended for US Healthcare Professionals only.

4.1.3 01/2023 | GLOOTH00001 04/2015 | © Lilly USA, LLC 2023. All rights reserved.

Product names listed above are trademarks or registered trademarks owned by or licensed to Eli Lilly and Company, its subsidiaries, or affiliates

Facebook Twitter
Lilly